GGrantIndex
← Leaderboards

Matthew H Porteus

California Institute Of Technology

$8,894,680
Attributed
$9,509,168
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY200521
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$9,509,168 · 8

By mechanism

R01$6,876,539 · 4
OT2$1,225,000 · 1
R21$784,604 · 2
K08$623,025 · 1

Top collaborators

Most similar at California Institute Of Technology

Same institution · by research overlap

Others in their field

Top investigators on “Mutation

Research focus

MutationGenesMediatingCellsCd34 GeneHomologous RecombinationNucleaseGene TherapyHematopoietic Stem CellsCell LineEngineeringAutologousTransplantationToxic EffectStem CellsGenome EditingReconstitutionBaseGene TargetingGuide RnaInnovationGene-ModifiedImmune SystemLife

Grant awards (29)

Homologous Recombination Mediated Gene Correction for the Hemoglobinopathies$395,344
R01 · FY2021 · HL · contact PI
Homologous Recombination Mediated Gene Correction for the Hemoglobinopathies$395,259
R01 · FY2020 · HL · contact PI
Genome editing to cure SCD$1,225,000
OT2 · FY2019 · HL · contact PI
Genome Editing by Homologous Recombination to Create HIV Resistant Immune System$401,420
R01 · FY2019 · AI · contact PI
Homologous Recombination Mediated Gene Correction for the Hemoglobinopathies$395,180
R01 · FY2019 · HL · contact PI
Genome Editing by Homologous Recombination to Create HIV Resistant Immune System$87,500
R01 · FY2019 · AI · contact PI
Genome Editing by Homologous Recombination to Create HIV Resistant Immune System$488,506
R01 · FY2018 · AI · contact PI
Homologous Recombination Mediated Gene Correction for the Hemoglobinopathies$395,103
R01 · FY2018 · HL · contact PI
Genome Editing to rescue FOXP3 Deficiency in IPEX syndrome$239,135
R21 · FY2018 · AI
Genome Editing by Homologous Recombination to Create HIV Resistant Immune System$400,618
R01 · FY2017 · AI · contact PI
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID$394,389
R01 · FY2017 · AI · contact PI
Genome Editing to rescue FOXP3 Deficiency in IPEX syndrome$199,558
R21 · FY2017 · AI
Genome Editing by Homologous Recombination to Create HIV Resistant Immune System$400,267
R01 · FY2016 · AI · contact PI
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID$393,000
R01 · FY2016 · AI · contact PI
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID$391,652
R01 · FY2015 · AI · contact PI
Genome Editing by Homologous Recombination to Create HIV Resistant Immune System$199,958
R01 · FY2015 · AI · contact PI
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID$390,344
R01 · FY2014 · AI · contact PI
Pre-Clinical Development of Nuclease Mediated Gene Therapy for SCID$365,731
R01 · FY2013 · AI · contact PI
Using Zinc Finger Nucleases to Stimulate Gene Targeting in HSC$343,006
R01 · FY2009 · HL · contact PI
Using Zinc Finger Nucleases to Stimulate Gene Targeting in HSC$343,006
R01 · FY2008 · HL · contact PI
Zinc Finger Nucleases to Stimulate Gene Targeting in Hematopoietic Stem Cells$343,006
R01 · FY2007 · HL · contact PI
Development of gene targeting in C. elegans and D. rerio using zinc finger$170,411
R21 · FY2007 · CA · contact PI
Using Zinc Finger Nucleases to Stimulate Gene Targeting in HSC$353,250
R01 · FY2006 · HL · contact PI
Development of gene targeting in C. elegans and D. rerio using zinc finger$175,500
R21 · FY2006 · CA · contact PI
The Genetics of Gene Targeting in Vertebrate Cells$124,200
K08 · FY2006 · HL · contact PI
The Genetics of Gene Targeting in Vertebrate Cells$124,200
K08 · FY2005 · HL
The Genetics of Gene Targeting in Vertebrate Cells$124,200
K08 · FY2004 · HL
The Genetics of Gene Targeting in Vertebrate Cells$124,200
K08 · FY2003 · HL
The Genetics of Gene Targeting in Vertebrate Cells$126,225
K08 · FY2002 · HL